PTC Therapeutics, Inc. Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax, Portion Attributable to Parent
PTC Therapeutics, Inc. (PTCT) reported Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax, Portion Attributable to Parent of $0 for the 3-month period ending 2022-06-30, per its 10-Q filed 2022-08-04.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent · last filed 2022-08-04
- PTC Therapeutics, Inc. other comprehensive income (loss), foreign currency translation adjustment, tax, portion attributable to parent for the quarter ending 2022-06-30 was $0.00.
- PTC Therapeutics, Inc. other comprehensive income (loss), foreign currency translation adjustment, tax, portion attributable to parent for the quarter ending 2022-03-31 was $0.00.
- PTC Therapeutics, Inc. other comprehensive income (loss), foreign currency translation adjustment, tax, portion attributable to parent for the quarter ending 2021-12-31 was $0.00.
- PTC Therapeutics, Inc. other comprehensive income (loss), foreign currency translation adjustment, tax, portion attributable to parent for the quarter ending 2021-09-30 was $0.00.
- PTC Therapeutics, Inc. other comprehensive income (loss), foreign currency translation adjustment, tax, portion attributable to parent for fiscal 2021 was $0.00.
- PTC Therapeutics, Inc. other comprehensive income (loss), foreign currency translation adjustment, tax, portion attributable to parent for fiscal 2020 was $0.00.
- PTC Therapeutics, Inc. other comprehensive income (loss), foreign currency translation adjustment, tax, portion attributable to parent for fiscal 2019 was $0.00.
- PTC Therapeutics, Inc. other comprehensive income (loss), foreign currency translation adjustment, tax, portion attributable to parent for fiscal 2018 was $0.00.
| Period end | Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax, Portion Attributable to Parent 3 month | Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax, Portion Attributable to Parent 6 month | Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax, Portion Attributable to Parent 9 month | Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax, Portion Attributable to Parent 12 month |
|---|---|---|---|---|
| 2022-06-30 | $0.00 10-Q · filed 2022-08-04 | $0.00 10-Q · filed 2022-08-04 | $0.00 derived: sum of 3 quarters · filed 2022-08-04 | $0.00 derived: sum of 4 quarters · filed 2022-08-04 |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-03 | $0.00 derived: sum of 2 quarters · filed 2022-05-03 | $0.00 derived: sum of 3 quarters · filed 2022-05-03 | $0.00 derived: sum of 4 quarters · filed 2022-08-04 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22 | $0.00 derived: sum of 2 quarters · filed 2022-02-22 | $0.00 derived: sum of 3 quarters · filed 2022-08-04 | $0.00 10-K · filed 2022-02-22 |
| 2021-09-30 | $0.00 10-Q · filed 2021-10-28 | $0.00 derived: sum of 2 quarters · filed 2022-08-04 | $0.00 10-Q · filed 2021-10-28 | $0.00 derived: sum of 4 quarters · filed 2022-08-04 |
| 2021-06-30 | $0.00 10-Q · filed 2022-08-04 | $0.00 10-Q · filed 2022-08-04 | $0.00 derived: sum of 3 quarters · filed 2022-08-04 | $0.00 derived: sum of 4 quarters · filed 2022-08-04 |
| 2021-03-31 | $0.00 10-Q · filed 2022-05-03 | $0.00 derived: sum of 2 quarters · filed 2022-05-03 | $0.00 derived: sum of 3 quarters · filed 2022-05-03 | $0.00 derived: sum of 4 quarters · filed 2022-05-03 |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22 | $0.00 derived: sum of 2 quarters · filed 2022-02-22 | $0.00 derived: sum of 3 quarters · filed 2022-02-22 | $0.00 10-K · filed 2022-02-22 |
| 2020-09-30 | $0.00 10-Q · filed 2021-10-28 | $0.00 derived: sum of 2 quarters · filed 2021-10-28 | $0.00 10-Q · filed 2021-10-28 | |
| 2020-06-30 | $0.00 10-Q · filed 2021-07-29 | $0.00 10-Q · filed 2021-07-29 | ||
| 2020-03-31 | $0.00 10-Q · filed 2021-05-04 | |||
| 2019-12-31 | $0.00 10-K · filed 2022-02-22 | |||
| 2018-12-31 | $0.00 10-K · filed 2021-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Veradermics, Inc (MANE) | United States | $4.839B | |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Edgewise Therapeutics, Inc. (EWTX) | United States | $4.470B | -22.23 |
| Viking Therapeutics, Inc. (VKTX) | United States | $4.287B | -8.51 |